- Filed
- Dec 17, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Dec 16, 2025 | 110.01M sh |
| Shares Diluted | FY 2025 · Sep 30, 2025 | 109.41M sh |
| Shares Diluted | FY 2025 · Sep 30, 2024 | 109.14M sh |
| Capex | FY 2025 · Sep 30, 2025 | $16K |
| Capex | FY 2025 · Sep 30, 2024 | $58K |
| Operating Cash Flow | FY 2025 · Sep 30, 2025 | $549K |
| Operating Cash Flow | FY 2025 · Sep 30, 2024 | $202K |
| Stockholders Equity | FY 2025 · Sep 30, 2025 | $50.01M |
| Stockholders Equity | FY 2025 · Sep 30, 2024 | $84.21M |
| Stockholders Equity | FY 2025 · Sep 30, 2023 | $109.3M |
| Current Liabilities | FY 2025 · Sep 30, 2025 | $7.69M |
| Current Liabilities restated | FY 2025 · Sep 30, 2024 | $9.32M |
| Total Liabilities | FY 2025 · Sep 30, 2025 | $9.99M |
| Total Liabilities restated | FY 2025 · Sep 30, 2024 | $11.69M |
| Current Assets | FY 2025 · Sep 30, 2025 | $31.68M |
| Current Assets restated | FY 2025 · Sep 30, 2024 | $35.4M |
| Total Assets | FY 2025 · Sep 30, 2025 | $60M |
| Total Assets restated | FY 2025 · Sep 30, 2024 | $95.9M |
| Eps Diluted | FY 2025 · Sep 30, 2025 | −$0.32 |
| Eps Diluted | FY 2025 · Sep 30, 2024 | −$0.22 |
| Sga Expense | FY 2025 · Sep 30, 2025 | $35.62M |
| Sga Expense restated | FY 2025 · Sep 30, 2024 | $39.81M |
| Net Income | FY 2025 · Sep 30, 2025 | −$34.75M |
| Net Income | FY 2025 · Sep 30, 2024 | −$24.1M |
| Operating Income | FY 2025 · Sep 30, 2025 | −$25.31M |
| Operating Income restated | FY 2025 · Sep 30, 2024 | −$25.7M |
| Gross Profit | FY 2025 · Sep 30, 2025 | $33.37M |
| Gross Profit restated | FY 2025 · Sep 30, 2024 | $36.14M |
| Cost Of Revenue | FY 2025 · Sep 30, 2025 | $63.13M |
| Cost Of Revenue restated | FY 2025 · Sep 30, 2024 | $70.79M |
| Revenue | FY 2025 · Sep 30, 2025 | $96.5M |
| Revenue restated | FY 2025 · Sep 30, 2024 | $106.94M |